Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-004571
Filing Date
2025-04-14
Accepted
2025-04-14 16:15:33
Documents
47
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 666143
2 ex31-1.htm EX-31.1 9790
3 ex31-2.htm EX-31.2 9922
4 ex32-1.htm EX-32.1 5327
5 ex32-2.htm EX-32.2 5070
  Complete submission text file 0001641172-25-004571.txt   3884115

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bmra-20250228.xsd EX-101.SCH 23442
7 XBRL CALCULATION FILE bmra-20250228_cal.xml EX-101.CAL 44878
8 XBRL DEFINITION FILE bmra-20250228_def.xml EX-101.DEF 102919
9 XBRL LABEL FILE bmra-20250228_lab.xml EX-101.LAB 252336
10 XBRL PRESENTATION FILE bmra-20250228_pre.xml EX-101.PRE 188735
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 551216
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 25836205
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)